Several new facilities opened across Ireland in 2018, including…
On November 16th, Agilent officially opened its new purpose-built R&D extension within its Little Island, Cork site. This new facility will allow both cell analysis and biosensor development.
The opening also marked the company’s integration of the newly acquired biotech start-up Luxcel Biosciences. The company celebrated the day by allowing academic and industry experts to tour the new facility.
Early in the year, Almac opened its new cold storage facility at its Craigavon headquarters. The 95,000 sq ft facility has been “purpose built in response to customer requirements”, with a focus on meeting the needs of new client product areas, changes to industry regulations and compliance in supply chain data.
This is one of largest such facilities in Europe and brought an estimated 100 new jobs to the area.
BD opened its new R&D site in Limerick in July, after a €21m investment. The site, known as BD’s Research Centre Ireland (RCI), brought 100 new jobs to Limerick.
The site was “established to serve as a global R&D hub” and is seen as key to the company’s long-term growth plans.
For more information about the site, check out this video from Silicon Republic with R&D site director Kieran O’Gorman…
In May, Gilead opened a €9.5m expansion of its Cork operations. The new quality control lab is expected to lead to increased production serving Europe, Middle East and Africa. The manufacture of 11 new products was moved to the Irish site recently, leading to this increase in demand for quality control testing.
In November 2017, Shire announced a $400m investment in a new biotech manufacturing facility in Dunboyne, Co Meath. A year later they held an “official site dedication event” to mark the progress on the 120 acre site. The facility is expected to be fully operational by 2020 and bring 400 jobs to the area. Recruitment for some roles has already begun.
Hear from Susan Hynes, Dunboyne Site Lead about the site and the type of candidates they’re looking for …
SK Biotech became the first South Korean pharmaceutical company to invest in Ireland as it officially opened its Swords manufacturing site at the start of 2018. The site will be manufacturing active pharmaceutical ingredients (APIs) on a contract basis. Although the company does intend to bring R&D and additional manufacturing, in the longer term.
West Pharmaceutical Services
West opened its new site in Waterford in July. The facility will serve as a Global Centre of Excellence within the company’s manufacturing activities. Initially the plant will employ approximately 100 people but there are already plans to increase this number over the next few years. The site will be producing packaging material for insulin used in pen injectors, as well as finishing for other components.
To find out more about West’s decision to invest in Waterford, check out this video from the the initial investment announcement in 2014…